Collaborative Medicinal Development LLC wins AU$1 million grant award from FightMND
Collaborative Medicinal Development LLC (CMD), announces that it was awarded a AU$1 million grant from FightMND to support a Phase 2 study of CuATSM for treatment ALS (amyotrophic lateral sclerosis),…